KSQ is deploying its CRISPRomics platform, which pinpoints therapeutic nodes that directly correlate genomic function to disease, for new drug development.
Location: United States, Massachusetts, Cambridge
Total raised: $156M
Investors 2
| Date | Name | Website |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Alpha Wave... | alphawaveg... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.09.2018 | Series C | $80M | - |
| 02.10.2017 | - | $76M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 28.09.2018 | KSQ Therapeutics Secures $80M Financing | CAMBRIDGE, MA, KSQ Therapeutics announced today that the company has secured an $80 million Series... | vcnewsdail... |
| 28.09.2018 | KSQ Therapeutics closes $80M Series C for cell therapy devel... | The company plans to use the funding to advance its first program into the clinic within the next ye... | medcitynew... |
| 28.09.2018 | KSQ Therapeutics Secures $80M Financing Round | KSQ Therapeutics, a Cambridge, MA-based developer of oncology drugs, secured an $80m Series C financ... | finsmes.co... |
| 28.09.2018 | KSQ Therapeutics Secures $80 Million | KSQ Therapeutics announced today that the company has secured an $80 million Series C financing to a... | citybizlis... |
| 28.09.2018 | Term Sheet — Friday, September 28 | THREE THINGS Good morning, Term Sheet readers. Paid Content Securing the enterprise without bounda... | fortune.co... |
| 03.10.2017 | Term Sheet — Tuesday, October 3 | DIRTY DEALINGS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see ... | fortune.co... |
| 02.10.2017 | KSQ raises $76M, names ex-Genzyme boss Meeker as CEO | KSQ Therapeutics has raised $76 million and named former Genzyme boss David Meeker as CEO. Meeker is... | fiercebiot... |
| 02.10.2017 | KSQ Therapeutics Raises $76 Million | CAMBRIDGE, Mass.--(BUSINESS WIRE)--KSQ Therapeutics emerged today with $76 million in financing and ... | citybizlis... |
| 02.10.2017 | KSQ Therapeutics Emerges with $76M Financing | CAMBRIDGE, MA, KSQ Therapeutics emerged today with $76 million in financing. >> Click here ... | vcnewsdail... |
| 02.10.2017 | KSQ Therapeutics Launches with $76M in Financing | KSQ Therapeutics, a Cambridge, MA-based drug development company, has just come out of stealth with ... | finsmes.co... |
Show more